Biosynthesis of a precursor to bovine parathyroid hormone has been demonstrated in slices of parathyroid tissue incubated in vitro. The proparathyroid hormone is 15-20 amino acids larger than the bovine hormone, and has a molecular weight of about 11,500 as determined by polyacrylamide gel electrophoresis. Upon incubation of parathyroid slices with [14Claminoacids, radioactivity is detected initially in the precursor. If incorporation of [14C]aminoacids is inhibited after a short incubation either by replacement of radioactive amino acids with unlabeled amino acids or by addition of puromycin, the amount of radioactivity in the precursor decreases, while the radioactivity in the hormone continues to increase. The precursor is bound by an antibody that is specific for parathyroid hormone, and its binding can be inhibited by addition of the hormone. Analysis of tryptic digests indicates that the precursor and the hormone have common tryptic peptides, and that there are at least two additional peptides in the precursor.
Parathyroid -hormone (PTH) regulates the concentration of plasma calcium in the circulation. The principal species of bovine PTH that is stored in, and extracted from, the parathyroid gland is a single polypeptide consisting of 84 amino acids (1, 2) . It is known that insulin is synthesized as a precursor of higher molecular weight (3) , and suggestive evidence has accumulated that several other peptide hormones have biosynthetic precursors (4) (5) (6) . Thus, PTH may also be derived from a precursor. Cohn, et al. have recently suggested that bovine PTH may be synthesized as a molecule larger than 84 amino acids (7) . However, the entire issue of a precursor to PTH has been confused by recent studies that suggest that PTH itself is an intracellular precursor of the circulating hormone, since the hormone secreted in vitro is smaller than 84 amino acids (8, 9) . In this report, we present evidence that a precursor to PTH is synthesized in parathyroid slices during incubations in vitro. The precursor contains 100-105 amino acids, and its conversion to PTH is readily demonstrated in parathyroid slices.
METHODS
Bovine parathyroid glands were obtained from a local abattoir and placed in cold Hank's balanced salt solution (Grand Island Biological Co.) immediately after removal from freshly killed animals. The glands were used in the experiments 2-3 hr later. The parathyroids were cut with a razor blade into Abbreviations: PTH, bovine parathyroid hormone containing 84 amino acids; pro PTH, bovine proparathyroid hormone; SDS, sodium dodecyl sulfate. 643 slices about 0.5-mm thick, and slices from 1-2 glands were incubated for 15 min in 2-3 ml of Hank's solution supplemented with 5% fetal-calf serum. Then, 4 MCi/ml of a [14C]-aminoacid mixture (New England Nuclear Corp.), with threonine and arginine omitted, and 10 ,Ci/ml of 10 ,000 X g for 10 min and then redissolved in 1 ml of 0.1 NaOH. After 10 min at room temperature, protein was again precipitated with cold 10% Cl;, CCOOH. After centrifugation for 10 min at 10,000 X g, the pellet was resuspended in 2 ml of distilled water and lyophilized to remove C13CCOOH. For gel electrophoresis, the lyophilized powder was extracted with 8 M urea-0.1 M acetic acid. This procedure recovered about 50% of the total radioactivity incorporated.
Gel Electrophoreesi. The lation fluid 0.4:0.04:0.56 at room temperature. The distribution of immunoreactive PTH was compared with the radioactive profile of the gels by cutting each slice in half and assay of one half for radioactivity; the other half was shaken overnight at 40C with 0.2 ml of 0.05 M Veronal buffer (pH 8.5)-10% human plasma. PTH in extracts from gel slices was assayed by a competitive-binding radioimmunoassay with 125I-labeled bovine PTH (12) .
For isolation of radioactive protein in the peaks from the acrylamide gels, each slice was shaken with 0.2 ml of 0.1 N acetic acid overnight at 4°C. Aliquots of eluant from each gel slice were assayed for radioactivity by scintillation counting. Fractions from the peaks were combined and lyophilized to dryness. The lyophilized powder was dissolved in 0.1-0. 4 more slowly than the protein in peak I. In the urea gel at pH 4.4 mobility is a function of both charge and molecular weight, while in the SDS-urea gel mobility is a function of molecular weight only (11) . Thus, the protein in peak II has a larger molecular weight than the protein in peak I, and its faster mobility on urea gels at pH 4.4 is the result of its higher content of positively-charged amino acids. The protein in peak II was isolated and carrier PTH was added. The molecular weight of the protein in peak II was determined from its mobility on the SDS-urea acrylamide gel by calibration of the gel with cytochrome c, cyanogen bromide fragments of cytochrome c, PTH, and the large cyanogen bromide fragment of PTH (Fig. 3) . From the slope of the curve, with immunoreactive PTH as an internal standard, the molecular weight of the peptide in peak II was estimated to be 11,500. Relative to PTH this is an increase of about 2000 daltons, which is equivalent to 15-20 additional amino acids.
Since the protein in peak II had a higher molecular weight than PTH, it seemed likely that it might be a precursor to PTH and should be synthesized before PTH. Fig. 4 summarizes the result of a kinetic study obtained by incubation of parathyroid slices with ['4C]aminoacids for 10, 20, 45, or 150 min. Only the regions of the gels containing the two peaks of radioactivity are shown. The amount of radioactivity plotted has been corrected for the amount of protein extracted from each sample. At 10 min, all the radioactivity is present in peak II. At longer times, radioactivity appears in peak I in progressively larger amounts relative to peak II, although the total radioactivity in both peaks continues to increase up to an elapsed time of 150 min.
Two additional experiments were done to demonstrate that the radioactivity in peak I is actually derived from peak II.
After 20 min of incubation with radioactive amino acids, they were removed and unlabeled amino acids were added to displace the isotope from rapidly turning-over molecules (see Methods). Additional incorporation of radioactivity into the peaks was effectively inhibited by this procedure. The amount of radioactivity in peak II began to decrease after an additional 10 min of incubation (Fig. 5, upper (3, 5, 6) cyanogen bromide fragments of cytochrome c: (3) 7760; (5) 2780; (6) )00 00 0 identical sequences. An analysis of the 3H-to-14C ratio in the peak containing the C-terminal peptide suggests that the additional amino acids of the protein in peak II were added onto the C-terminal end. Fig. 6 , (upper panel), indicate that most of the tryptic peptides are similar for the two proteins. Two major peaks of radioactivity that migrate from the origin are observed (13-18 cm, 20-25 cm), and these correspond to major spots that can be visualized with ninhydrin of purified PTH (15) . Both lysine and dilysine (fastest-migrating peak) are liberated during the digestion (Fig 6, upper panel) . There are two additional peaks (marked by arrows) in the material from peak II that migrate rapidly relative to the majority of the trypic peptides; the fastest peak trails behind the dilysine peak. Since the protein in peak II is larger than PTH, but migrates faster on the urea-acrylamide gel, the additional 15-20 amino acids must contain a substantial number of basic amino acids. The extra, rapidly migrating, basic peptides observed after tryptic digestion are in agreement with this observation.
The peptides in each of the two major peaks of Fig. 6 (upper panel) were eluted and then chromatographed on paper (Fig. 6, lower panel) . The first major peak (13-18 cm) separated into two major and one minor component. The second major peak (20-25 cm) separated into one major and four minor components. Each component contained both 3H and 14C radioactivity, thereby providing substantial evidence that the proteins in peaks I and II contain peptides with DISCUSSION Our findings, in addition to the data presented by Cohn et al. (7) , establish the existence of a precursor to parathyroid hormone. The peptide in peak II isolated from the electrophoretic gels is about [15] [16] [17] [18] [19] [20] amino acids larger than PTH. Neither protein contains threonine. Radioactive amino acids are first detected in peak II, and, if further incorporation of radioactivity is blocked, the radioactivity in the protein of peak II is depleted with a corresponding increase in radioactivity of PTH in peak I. The protein in peak II contains peptides with sequences that are identical to those of PTH, since it can bind specifically to an antibody against PTH and has tryptic peptide peaks corresponding to PTH on electrophoresis and on paper chromatography. We conclude from these data that the protein in peak II is an intracellular precursor to PTH, and we suggest that it be designated proparathyroid hormone (proPTH). However, it is clear that further work will be necessary to demonstrate that the pro-PTH described here, rather than an even larger polypeptide, is the direct product synthesized on the messenger RNA for PTH.
Little The data presented in the paper lend further support to the previously reported observation that certain human parathyroid adenomas appear to secrete an immunoreactive PTH of a higher molecular weight than the 84 amino-acid hormone (18) . It seems likely that human PTH also is synthesized as a precursor of higher molecular weight, and that it may be secreted by tumors of the parathyroids in a manner similar to the secretion of proinsulin by islet cell tumors (19) .
The discovery of proinsulin was the first demonstration that a biosynthetic precursor to a polypeptide hormone existed (3). Since then, eyidence has been' reported suggesting the existence of precursors of higher molecular weight for other hormones (4) (5) (6) . The function and significance of prohormones are unknown; they may simply be an intermediate in the continuing molecular evolution of proteins in vertebrates. On the other hand, the emerging generality of prohormones for polypeptide hormones, and the specific mechanisms required for cleavage, strongly suggest some function for the prohormone. In the case of other nonhormonal proteins, such as the pancreatic proteases, the proenzyme is inactive and thus prevents self-digestion (20) . After reduction of disulfide bonds, proinsulin renatures to an active form more efficiently than does insulin (21) . This observation suggests that the connecting peptide in proinsulin insures the proper folding necessary for the disulfide bridges of insulin to form. However, there seems to be no reason for PTH to be synthesized in an inactive form, since an active form is stored in the gland, and furthermore PTH contains no cysteines that are required for the formation of disulfide bridges as in insulin. Thus, the extra amino acids may play some role in the postsynthetic transport and packaging of the hormone in the cell, or perhaps the conversion of proPTH to PTH provides an additional point for control of the secretion of PTH.
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